Rieser NM
Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich and University of Zurich, Zurich, Switzerland.
ArticlePsilocybin
Effects of psychedelic drug use on neurocognitive function and the psychological and social domains of quality of life: an international online study.
ArticleKetamine
Psychedelics in Mental Health: Opportunities and Challenges.
ArticlePsilocybin
Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers.
ArticlePsilocybin
Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorder.
ArticlePsychedelics
Neurobiological Correlates of Psychedelic Experiences and Psychedelic-Associated Adverse Effects.
ArticlePsilocybin
The emotional architecture of the psychedelic brain.
PreprintPsilocybin
Epigenome-wide Association Study of Psilocybin-Induced Methylome Changes in Alcohol Use Disorder
ArticlePsilocybin
Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial.
ArticlePsilocybin
A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.
ArticlePsilocybin
Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differences.
ArticlePsilocybin
Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and Meditation.
ArticlePsilocybin
Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial.
ArticlePsilocybin